Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective”

The morbidity of whole gland treatment for prostate cancer is significant. Given the low risk of prostate cancer specific mortality for most men diagnosed with prostate cancer, alternative therapies such as sub-total or hemi-ablation of the prostate and focal ablation of prostate tumors are being in...

Descripción completa

Detalles Bibliográficos
Autores principales: Metwalli, Adam R, Pinto, Peter A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750819/
https://www.ncbi.nlm.nih.gov/pubmed/23915359
http://dx.doi.org/10.1186/1471-2490-13-39
_version_ 1782281479988969472
author Metwalli, Adam R
Pinto, Peter A
author_facet Metwalli, Adam R
Pinto, Peter A
author_sort Metwalli, Adam R
collection PubMed
description The morbidity of whole gland treatment for prostate cancer is significant. Given the low risk of prostate cancer specific mortality for most men diagnosed with prostate cancer, alternative therapies such as sub-total or hemi-ablation of the prostate and focal ablation of prostate tumors are being investigated. The developing role of imaging for prostate tumors will dramatically change and likely improve the treatment morbidity for low risk prostate tumors. Commentary on: http://www.biomedcentral.com/1471-2490/13/2.
format Online
Article
Text
id pubmed-3750819
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37508192013-08-24 Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective” Metwalli, Adam R Pinto, Peter A BMC Urol Commentary The morbidity of whole gland treatment for prostate cancer is significant. Given the low risk of prostate cancer specific mortality for most men diagnosed with prostate cancer, alternative therapies such as sub-total or hemi-ablation of the prostate and focal ablation of prostate tumors are being investigated. The developing role of imaging for prostate tumors will dramatically change and likely improve the treatment morbidity for low risk prostate tumors. Commentary on: http://www.biomedcentral.com/1471-2490/13/2. BioMed Central 2013-08-02 /pmc/articles/PMC3750819/ /pubmed/23915359 http://dx.doi.org/10.1186/1471-2490-13-39 Text en Copyright © 2013 Metwalli and Pinto; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Metwalli, Adam R
Pinto, Peter A
Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective”
title Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective”
title_full Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective”
title_fullStr Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective”
title_full_unstemmed Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective”
title_short Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective”
title_sort commentary on: “focal cryosurgical ablation of the prostate: a single institute’s perspective”
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750819/
https://www.ncbi.nlm.nih.gov/pubmed/23915359
http://dx.doi.org/10.1186/1471-2490-13-39
work_keys_str_mv AT metwalliadamr commentaryonfocalcryosurgicalablationoftheprostateasingleinstitutesperspective
AT pintopetera commentaryonfocalcryosurgicalablationoftheprostateasingleinstitutesperspective

Ejemplares similares